KalVista Pharmaceuticals, Inc. (KALV) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -14.46M | 45.36M | 0 | -54.5M | -40.36M | -32.68M | -39.64M | -40.22M | -15.11M | -27.57M | -19.82M | -26.73M |
| Operating CF Margin % | -35.37% | 75.7% | - | -3822.02% | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 64.19% | 238.81% | 100% | -35.51% | -167.22% | -18.53% | -99.96% | -50.47% | 33.27% | -196.81% | 3.73% | -17.54% |
| Net Income | -23.49M | -5.37M | -49.48M | -60.1M | -52.23M | -48.51M | -42.27M | -40.44M | -44.65M | -29.03M | -27.65M | -25.32M |
| Depreciation & Amortization | 355K | 586.5K | 0 | 252K | 275K | 229K | 227K | 224K | 219K | 207K | 197K | 199K |
| Stock-Based Compensation | 0 | 0 | 0 | 5.38M | -8.65M | 2.61M | 0 | 3.04M | 12.74M | 2.71M | 3.21M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 12.86M | 63.6M | 49.48M | 4.66M | 1.45M | 7.39M | 2.19M | -731K | -28K | -429K | 613K | 2.61M |
| Working Capital Changes | -4.18M | -13.45M | 0 | -4.7M | 18.79M | 5.59M | 213K | -2.31M | 16.61M | -1.03M | 3.81M | -4.22M |
| Change in Receivables | -8.68M | -12.24M | 0 | -1.1M | 2.79M | 3.16M | -1.07M | -1.25M | 14.39M | -2.11M | -2.02M | -2.08M |
| Change in Inventory | -665K | -2.97M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -149K | -1.9M | 0 | 2.51M | -1.39M | 779K | -5.86M | 1.5M | 6.1M | -1.94M | 55K | 108K |
| Cash from Investing | -901K | -1.19M | 0 | 21.26M | -3.33M | 8.52M | 48.67M | 37.16M | -126.19M | -6.7M | 28.56M | 19.61M |
| Capital Expenditures | -203K | 361K | 0 | -290K | 24K | -24K | -108K | -21K | -15K | -19K | -2K | -6K |
| CapEx % of Revenue | 0.5% | 0.6% | - | 20.34% | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | -12K | 0 | 0 | 434K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | -147K | -63.08M | -103K | -94K | -64K | -107K | -91K | -203K | 0 |
| Cash from Financing | 1.47M | -1.75M | 0 | 23.21M | 4.66M | 151.77M | 295K | 3M | 150.1M | 284K | 128K | 204K |
| Debt Issued (Net) | 0 | 22K | 0 | 21.92M | 2.81M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 1.47M | -1.77M | 0 | 1.29M | 1.85M | 0 | 295K | 3M | 96.94M | 284K | 128K | 204K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 151.77M | 0 | 0 | 53.15M | 0 | 0 | 0 |
| Net Change in Cash | -15.57M | -14.15M | 119.19M | -7.31M | -35.67M | 126.36M | 9.73M | 59K | 8.73M | -34.61M | 8.26M | -6.83M |
| Free Cash Flow | -14.58M | 45.52M | 0 | -54.79M | -40.01M | -32.81M | -39.75M | -40.24M | -15.23M | -27.59M | -19.83M | -26.74M |
| FCF Margin % | -35.67% | 75.96% | - | -3842.36% | - | - | - | - | - | - | - | - |
| FCF Growth % | 63.57% | 238.75% | 100% | -36.16% | -162.78% | -18.91% | -100.48% | -50.51% | 32.94% | -196.54% | 4.61% | -12.99% |
| FCF per Share | -0.29 | 0.90 | - | -1.02 | -0.81 | -0.62 | -0.85 | -0.87 | -0.35 | -0.79 | -0.57 | -0.78 |
| FCF Conversion (FCF/Net Income) | 0.62x | -8.44x | - | 0.91x | 0.77x | 0.67x | 0.94x | 0.99x | 0.34x | 0.95x | 0.72x | 1.06x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |